Lineage Cell Therapeutics In shares owned by BlackRock
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $13M | 8.5M | 1.48 |
| 2023-09-30 | $11M | 9.3M | 1.18 |
| 2023-06-30 | $13M | 9.0M | 1.41 |
| 2023-03-31 | $5.6M | 3.7M | 1.50 |
| 2022-12-31 | $4.4M | 3.8M | 1.17 |
| 2022-06-30 | $6.2M | 3.8M | 1.64 |
| 2021-06-30 | $24M | 8.5M | 2.85 |
| 2021-03-31 | $5.9M | 2.5M | 2.40 |
| 2020-12-31 | $2.8M | 1.6M | 1.77 |
| 2020-09-30 | $1.5M | 1.6M | 0.95 |
| 2020-03-31 | $6.1M | 7.3M | 0.83 |
| 2019-12-31 | $6.5M | 7.3M | 0.89 |
| 2019-09-30 | $7.1M | 7.3M | 0.98 |